Table 1.
Survivors (%) | Sibling (%) | P-value | |
---|---|---|---|
Sample size | 307 | 97 | |
Sex | |||
Female | 184 (60) | 54 (56) | 0.48 |
Male | 123 (40) | 43 (44) | |
Race | |||
White | 272 (89) | 85 (88) | 0.83 |
Black | 16 (5) | 4 (4) | |
Hispanic | 4 (1) | 2 (2) | |
Other race | 15 (5) | 6 (6) | |
Current age | |||
<18 | 129 (42) | 58 (60) | 0.002 |
18–20 | 178 (58) | 39 (40) | |
Diagnosis | |||
Leukemia | 95 (31) | - | - |
CNS tumor | 40 (13) | - | - |
Hodgkins disease | 0 (0) | - | - |
NHL | 4 (1) | - | - |
Wilms tumor | 56 (18) | - | - |
Neuroblastoma | 90 (29) | - | - |
Soft tissue sarcoma | 19 (6) | - | - |
Bone tumor | 3 (1) | - | - |
Age at diagnosis | |||
0–1 | 198 (65) | - | - |
2–3 | 109 (35) | - | - |
Treatment | |||
Chemotherapy | 144 (49) | - | - |
Any Radiation | 11 (4) | - | - |
Chemo + Any Rad | 99 (33) | - | - |
Surgery only | 41 (14) | - | - |
Note: Fisher’s Exact tests were used evaluate p-values for the comparison between cases and siblings